Winslow, Evans & Crocker, Inc. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q4 2020$1,065,000
+44.9%
5,558
+11.5%
0.20%
+11.0%
Q3 2020$735,000
+24.4%
4,983
+4.2%
0.18%
+15.2%
Q2 2020$591,000
+51.5%
4,783
+18.8%
0.16%
+23.4%
Q1 2020$390,000
+9650.0%
4,026
+11741.2%
0.13%
+12700.0%
Q4 2019$4,0000.0%340.0%0.00%0.0%
Q3 2019$4,000340.00%
Other shareholders
REPLIGEN CORP shareholders Q4 2020
NameSharesValueWeighting ↓
12 West Capital Management LP 1,102,383$211,250,0009.08%
Ranger Investment Management 339,771$65,110,0003.43%
Pinz Capital Management, LP 36,400$6,975,0003.17%
Conestoga Capital Advisors, LLC 1,021,918$195,830,0003.12%
Ally Bridge Group (NY) LLC 82,500$15,809,0002.71%
AWM Investment Company, Inc. 100,000$19,163,0002.44%
Nicholas Investment Partners, LP 130,491$25,006,0001.93%
BBR PARTNERS, LLC 120,221$23,038,0001.91%
FRIESS ASSOCIATES LLC 129,430$24,803,0001.83%
Stephens Investment Management Group LLC 628,456$120,431,0001.79%
View complete list of REPLIGEN CORP shareholders